docetaxel anhydrous has been researched along with mtt formazan in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (mtt formazan) | Trials (mtt formazan) | Recent Studies (post-2010) (mtt formazan) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 690 | 1 | 136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabritius, M; Ip, C; Wu, Y | 1 |
| Juan, Z; Liu, C; Liu, D; Liu, Z; Wang, L; Zhang, N | 1 |
2 other study(ies) available for docetaxel anhydrous and mtt formazan
| Article | Year |
|---|---|
Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Death; Cell Line, Tumor; Docetaxel; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme-Linked Immunosorbent Assay; Formazans; Heat-Shock Proteins; Humans; Male; Molecular Chaperones; Organoselenium Compounds; Paclitaxel; Prostatic Neoplasms; RNA, Small Interfering; Taxoids; Tetrazolium Salts; Thapsigargin; Time Factors; Transcription Factor CHOP; Transfection | 2009 |
Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Female; Formazans; Humans; Lecithins; Lipids; Melanoma; Mice; Nanoparticles; Neoplasms; Ovarian Neoplasms; Particle Size; Suspensions; Taxoids; Tetrazolium Salts; Tissue Distribution | 2011 |